A Meta-Analysis of Adalimumab for Fistula in Crohn’s Disease
Purpose. This study aimed to evaluate the therapeutic value of adalimumab (ADA) for fistula in Crohn’s disease (CD). Methods. A computerized search of electronic databases, including PubMed, Web of Science, Embase, Google scholar, and the Cochrane Library from 2000 to October 2016, was performed. Ra...
Saved in:
Main Authors: | Yin-mei Fu, Ming Chen, Ai-jun Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2017/1745692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Adalimumab in Canadian Patients with Moderate to Severe Crohn’s Disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn’s DiseaSe (ACCESS) Trial
by: Remo Panaccione, et al.
Published: (2011-01-01) -
Acute Pancreatitis: An Unusual Side Effect of Adalimumab in Crohn’s Disease Patient
by: Walid El Ouardi, et al.
Published: (2025-01-01) -
Establishment and internal validation of a model to predict the efficacy of Adalimumab in Crohn’s disease
by: Fang Wang, et al.
Published: (2025-01-01) -
Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01) -
Management of Anal Fistula with Crohn's Disease
by: Shota Takano, et al.
Published: (2025-01-01)